Compare Novavax Inc (NVAX) vs PAGSEG Inc (PAGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs PAGSEG Inc — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while PAGSEG Inc trades at $9.61 (market cap $2.60B). The key difference: PAGSEG Inc is far larger — about 2× Novavax Inc's market cap, and PAGSEG Inc pays a 11.19% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | PAGS | |
|---|---|---|
Market Cap | $1.30B | $2.60B |
Sector | Health | Technology |
52-Week High | $11.19 | $12.00 |
52-Week Low | $6.22 | $7.75 |
Enterprise Value | $800.50M | $10.23B |
Dividend Yield | — | 11.19% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About PAGSEG Inc
PagSeguro Digital Ltd. is a leading provider of financial technology solutions in Brazil, primarily focused on e-commerce, face-to-face transactions, and financial services. The company's main offerings include PagBank, a digital banking platform, and PagSeguro, a suite of payment processing solutions that includes point-of-sale devices and online payment gateways. PAGS targets micro-merchants, small and medium-sized enterprises (SMEs), and consumers, aiming to democratize access to financial services in the country.
Read more on PAGS →
